Article
Drugmakers' shares stabilise after Zantac litigation slump
Rating:
0.0
Views:
74
Likes:
1
Library:
1
Shares in GSK , Sanofi , Haleon and Pfizer began to recover on Friday after the companies said that nothing material had changed regarding U.S. litigation focused on heartburn drug Zantac.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value